Patent 7098182 was granted and assigned to Microbial Technics Limited on August, 2006 by the United States Patent and Trademark Office.
Novel protein antigens from Group B Streptococcus are described, together with nucleic acid sequences encoding them. Their use in vaccines and screening methods is also described.